Medy-Tox Inc. (KOSDAQ:086900)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biotechnology	228.62B	221.12B	195.10B	184.87B	140.83B
Biotechnology Growth	3.39%	13.34%	5.53%	31.27%	-31.60%
Total	228.62B	221.12B	195.10B	184.87B	140.83B
Total Growth	3.39%	13.34%	5.53%	31.27%	-31.60%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	84.21B	79.82B	66.70B	59.72B	44.26B
South Korea Growth	5.50%	19.66%	11.70%	34.92%	-43.63%
Asia (Excl. South Korea)	67.28B	73.71B	69.18B	49.78B	69.45B
Asia (Excl. South Korea) Growth	-8.72%	6.56%	38.96%	-28.32%	-24.65%
Europe	8.54B	6.56B	6.55B	4.00B	2.31B
Europe Growth	30.09%	0.15%	63.91%	72.88%	-49.75%
Middle East	7.99B	8.54B	4.93B	3.71B	4.19B
Middle East Growth	-6.42%	73.19%	32.88%	-11.54%	-22.43%
America	56.52B	48.30B	43.63B	64.52B	20.25B
America Growth	17.02%	10.69%	-32.38%	218.59%	-17.86%
Other	235.50M	226.72M	465.97M	-	-
Other Growth	3.87%	-51.35%	-	-	-
Oceania	-	-	-	132.85M	132.60M
Oceania Growth	-	-	-	0.18%	-11.36%
Africa	-	-	-	207.54M	222.74M
Africa Growth	-	-	-	-6.82%	-42.36%
Total	224.77B	217.16B	191.46B	182.07B	140.83B
Total Growth	3.51%	13.42%	5.16%	29.29%	-31.60%

Source: S&P Global Market Intelligence.